{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T01:40:31Z","timestamp":1683855631349},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1007\/s11906-002-0065-7","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T20:11:30Z","timestamp":1180123890000},"page":"365-368","source":"Crossref","is-referenced-by-count":10,"title":["Renal dysfunction as a cardiovascular risk factor"],"prefix":"10.1007","volume":"4","author":[{"given":"Eberhard","family":"Ritz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Dikow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"65_CR1","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1053\/ajkd.2001.27392","volume":"38","author":"AJ Collins","year":"2001","unstructured":"Collins AJ, Li S, Ma SZ, Herzog C: Cardiovascular disease in end-stage renal patients. Am J Kidney Dis 2001, 38:S26-S29. An extensive updated review on death rates from cardiovascular disease in patients with end-stage renal disease. Specific discussion of types of events and epidemiologic details.","journal-title":"Am J Kidney Dis"},{"key":"65_CR2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","volume":"13","author":"JT Kielstein","year":"2002","unstructured":"Kielstein JT, Boger RH, Bode-Boger SM, et al.: Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 2002, 13:170\u2013176.","journal-title":"J Am Soc Nephrol"},{"key":"65_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1681\/ASN.V111105","volume":"11","author":"F Kronenberg","year":"2000","unstructured":"Kronenberg F, Kuen E, Ritz E, et al.: Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000, 11:105\u2013115.","journal-title":"J Am Soc Nephrol"},{"key":"65_CR4","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","volume":"12","author":"IH Klein","year":"2001","unstructured":"Klein IH, Ligtenberg G, Oey PL, et al.: Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 2001, 12:2427\u20132433.","journal-title":"J Am Soc Nephrol"},{"key":"65_CR5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ki.1996.444","volume":"50","author":"A Stefanski","year":"1996","unstructured":"Stefanski A, Schmidt KG, Waldherr R, Ritz E: Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 1996, 50:1321\u20131326.","journal-title":"Kidney Int"},{"key":"65_CR6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","volume":"53","author":"D Fliser","year":"1998","unstructured":"Fliser D, Pacini G, Engelleiter R, et al.: Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998, 53:1343\u20131347.","journal-title":"Kidney Int"},{"key":"65_CR7","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/ndt\/15.suppl_5.81","volume":"15","author":"ZA Massy","year":"2000","unstructured":"Massy ZA: Importance of homocysteine, lipoprotein(a) and non-classical cardiovascular risk factors (fibrinogen and advenced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant 2000, 15:S81-S91.","journal-title":"Nephrol Dial Transplant"},{"key":"65_CR8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1523-1755.2002.00299.x","volume":"61","author":"CY Hsu","year":"2002","unstructured":"Hsu CY, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 2002, 61:1567\u20131576. An indepth analysis of methodologic issues relating to studies in mild to moderate chronic renal insufficiency, with particular emphasis on the reliability of S-Cr and algorithms to calculate GFR.","journal-title":"Kidney Int"},{"key":"65_CR9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/ndt\/16.5.1042","volume":"16","author":"L Duncan","year":"2001","unstructured":"Duncan L, Heathcote J, Djurdjev O, Levin A: Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001, 16:1042\u20131046.","journal-title":"Nephrol Dial Transplant"},{"key":"65_CR10","first-page":"A1025","volume":"12","author":"J Coresh","year":"2001","unstructured":"Coresh J, Astor BC, Muntner PM, et al.: Estimates of glomerular filtration rate in the United States population: Third National Health and Nutrition Examination (NHANES III). J Am Soc Nephrol 2001, 12:A1025.","journal-title":"J Am Soc Nephrol"},{"key":"65_CR11","first-page":"S1","volume":"39","author":"National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K\/DOQI) Advisory Board","year":"2002","unstructured":"National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K\/DOQI) Advisory Board: K\/DOQI clinical practise guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney disease outcome quality initiative. Am J Kidney Dis 2002, 39:S1-S246. An official statement of the National Kidney Foundation with a updated proposal concerning the definition of the stages of renal failure and accepted modalities of patient management.","journal-title":"Am J Kidney Dis"},{"key":"65_CR12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al.: A more accurate method to estimate glomerular rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461\u2013470.","journal-title":"Ann Intern Med"},{"key":"65_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2796.2001.00833.x","volume":"249","author":"HL Hillege","year":"2001","unstructured":"Hillege HL, Janssen WM, Bak AA, et al.: Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001, 249:519\u2013526. A large epidemiologic study in the general population (Groningen, The Netherlands) that documents the prevalence of microalbuminuria and proteinuria and associated factors.","journal-title":"J Intern Med"},{"key":"65_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"HL Hillege","year":"2000","unstructured":"Hillege HL, Girbes AR, de Kam PJ, et al.: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000, 102:203\u2013210.","journal-title":"Circulation"},{"key":"65_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","unstructured":"Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000, 355:253\u2013259.","journal-title":"Lancet"},{"key":"65_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007890-200108150-00014","volume":"72","author":"JI Roodnat","year":"2001","unstructured":"Roodnat JI, Mulder PG, Rischen-Vos J, et al.: Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001, 72:438\u2013444.","journal-title":"Transplantation"},{"key":"65_CR17","volume-title":"Arterial Pressure and Hypertension: Circulatory Physiology III","author":"AC Guyton","year":"1980","unstructured":"Guyton AC: Arterial Pressure and Hypertension: Circulatory Physiology III. Philadelphia: WB Saunders Company; 1980."},{"key":"65_CR18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/08037059409102258","volume":"3","author":"B Folkow","year":"1994","unstructured":"Folkow B: Kidneys in primary hypertension \u2014 initiators, stabilizers or\/and victim-aggravators? Blood Press 1994, 3:212\u2013215.","journal-title":"Blood Press"},{"key":"65_CR19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/01.HYP.23.6.1018","volume":"23","author":"A Minram","year":"1994","unstructured":"Minram A, Rbstein J, DuCalair G: Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994, 23:1018\u20131021.","journal-title":"Hypertension"},{"key":"65_CR20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","volume":"134","author":"JFE Mann","year":"2001","unstructured":"Mann JFE, Gerstein HC, Pogue J, et al.: Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: the HOPE randomization trial. Ann Intern Med 2001, 134:629\u2013636. An analysis of serum creatinine as a predictor of cardiovascular outcomes in the large HOPE trial, documenting that serum creatinine above 1.4 mg\/dL increases the risk of cardiovascular events by a factor of 1.6.","journal-title":"Ann Intern Med"},{"key":"65_CR21","first-page":"93","volume":"15","author":"WB Kannel","year":"1985","unstructured":"Kannel WB, McGee DL: Epidemiology of sudden death: insights from the Framingham study. Cardiol Clin 1985, 15:93\u2013105.","journal-title":"Cardiol Clin"},{"key":"65_CR22","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0735-1097(01)01627-8","volume":"38","author":"LM Ruilope","year":"2001","unstructured":"Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF: Renal function: The Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001, 38:1782\u20131787. An exhaustive review on the relation between renal function and cardiovascular risk with a thorough updated list of references.","journal-title":"J Am Coll Cardiol"},{"key":"65_CR23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.279.8.585","volume":"279","author":"LP Fried","year":"1998","unstructured":"Fried LP, Kronmal RA, Newman AB, et al.: Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998, 279:585\u2013592.","journal-title":"JAMA"},{"key":"65_CR24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","volume":"12","author":"LM Ruilope","year":"2001","unstructured":"Ruilope LM, Salvetti A, Jamerson K, et al.: Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol 2001, 12:218\u2013225. A post hoc analysis of the data from the HOT study that documents, based on a large database, the cardiovascular risk implications of increased serum creatinine and reduced creatinine clearance.","journal-title":"J Am Soc Nephrol"},{"key":"65_CR25","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","volume":"56","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Wilson PWF, et al.: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999, 56:2214\u20132219.","journal-title":"Kidney Int"},{"key":"65_CR26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0002-8703(84)90763-4","volume":"108","author":"WB Kannel","year":"1984","unstructured":"Kannel WB, Stampfer MJ, Castelli WP, et al.: The prognostic significance of proteinuria. Am Heart J 1984, 108:1347\u20131352.","journal-title":"Am Heart J"},{"key":"65_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004872-199602000-00011","volume":"14","author":"B Agarwal","year":"1996","unstructured":"Agarwal B, Berger A, Wolf K, et al.: Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996, 14:223\u2013228.","journal-title":"J Hypertens"},{"key":"65_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00041552-200003000-00008","volume":"9","author":"VM Campese","year":"2000","unstructured":"Campese VM, Bianchi S, Bigazzi R: Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension? Curr Opin Nephrol Hypertens 2000, 9:143\u2013147.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"65_CR29","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","volume":"161","author":"V Witko-Sarsat","year":"1998","unstructured":"Witko-Sarsat V, Friedlaender M, Nguyen Khoa T, et al.: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524\u20132532.","journal-title":"J Immunol"},{"key":"65_CR30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.HYP.20.1.10","volume":"20","author":"GM London","year":"1992","unstructured":"London GM, Guerin AP, Pannier B, et al.: Increased systolic pressure in chronic uremia: role of arterial wave reflection. Hypertension 1992, 20:10\u201319.","journal-title":"Hypertension"},{"key":"65_CR31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00004872-199611000-00001","volume":"14","author":"LM Ruilope","year":"1996","unstructured":"Ruilope LM, Campo C, Rodriguez-Artalejo et al.: Blood pressure and renal function: therapeutic implications. J Hypertens 1996, 14:1259\u20131263.","journal-title":"J Hypertens"},{"key":"65_CR32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ndt\/14.1.86","volume":"14","author":"B Csiky","year":"1999","unstructured":"Csiky B, Kovacs T, Wagner L, et al.: Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy. Nephrol Dial Transplant 1999, 14:86\u201390.","journal-title":"Nephrol Dial Transplant"},{"key":"65_CR33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1995.361","volume":"48","author":"RD Toto","year":"1995","unstructured":"Toto RD, Mitchell HC, Smith RD, et al.: \u201cStrict\u201d blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995, 48:851\u2013859.","journal-title":"Kidney Int"},{"key":"65_CR34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","volume":"123","author":"JC Pedersen","year":"1995","unstructured":"Pedersen JC, Adler S, Burkart JM, et al.: The Modification of Diet in Renal Disease study. Ann Intern Med 1995, 123:754\u2013762.","journal-title":"Ann Intern Med"},{"key":"65_CR35","first-page":"63A","volume":"11","author":"TH Jafar","year":"2000","unstructured":"Jafar TH, Schmid CH, Stark PC, et al.: The optimal level of blood pressure and urine protein excretion for the prevention of progression of chronic renal disease. J Am Soc Nephrol 2000, 11:63A.","journal-title":"J Am Soc Nephrol"},{"key":"65_CR36","first-page":"S171","volume":"45","author":"LM Ruilope","year":"1994","unstructured":"Ruilope LM, Acazar JM, Hernandez E, et al.: Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994, 45:S171-S173.","journal-title":"Kidney Int"},{"key":"65_CR37","doi-asserted-by":"crossref","first-page":"38E","DOI":"10.1016\/S0002-9149(99)80502-5","volume":"76","author":"I Sihm","year":"1995","unstructured":"Sihm I, Shroeder AP, Aalkjaer C, et al.: Regression of media-tolumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensinconverting enzyme inhibitor based regimen in hypertensive patients. Am J Cardiol 1995, 76:38E-40E.","journal-title":"Am J Cardiol"},{"key":"65_CR38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.25.4.699","volume":"25","author":"EL Shiffrin","year":"1995","unstructured":"Shiffrin EL, Deng LY: Comparison of the effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995, 25:699\u2013703.","journal-title":"Hypertension"},{"key":"65_CR39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/hy09t1.096184","volume":"38","author":"J Segura","year":"2001","unstructured":"Segura J, Campo C, Rodicio JL, Ruilope LM: ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis. Hypertension 2001, 38:645\u2013649.","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-002-0065-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0065-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T01:09:20Z","timestamp":1683853760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-002-0065-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s11906-002-0065-7","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}